NTSAD - Home

Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

Support NTSAD Families

More than 750 individuals and families affected by Tay-Sachs, Canavan, GM1, and Sandhoff find connection and community at NTSAD. Supporting families is the center of everything we do. Watch our new video featuring NTSAD families.

1

Latest News

Executive Leadership Transition
After 14 years, Sue Kahn plans to step down. Read More
News from Queen’s University
GM2 Gene Therapy Enrolling at Queen’s University Read More
Lysogene Trial Recruiting
Lysogene recruiting for LYS-GM101 gene therapy Read More

1
2
3

› ‹

NTSAD leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.

Default
Title
Date
Random

Tweets by @ntsad

Login